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Background: Evaluating the impact of genomic variations (GV) on protein-coding transcripts is an important step
in identifying variants of functional significance. Currently available programs for variant annotation depend on
external databases or annotate multiple variants affecting the same transcript independently, which limits program
use to organisms available in these databases or results in potentially incorrect or incomplete annotations.
Findings: We have developed CooVar (Co-occurring Variant Analyzer), a database-independent program for
assessing the impact of GVs on protein-coding transcripts. CooVar takes GVs, reference genome sequence, and
protein-coding exons as input and provides annotated GVs and transcripts as output. Other than similar programs,
CooVar considers the combined impact of all GVs affecting the same transcript, generating biologically more
accurate annotations. CooVar is operated from the command-line and supports standard file formats VCF, GFF/GTF,
and GVF, which makes it easy to integrate into existing computational pipelines. We have extensively tested CooVar
on worm and human data sets and demonstrate that it generates correct annotations in only a short amount of
time.
Conclusions: CooVar is an easy-to-use and lightweight variant annotation tool that considers the combined impact
of GVs on protein-coding transcripts. CooVar is freely available at http://genome.sfu.ca/projects/coovar/.
Keywords: Variant effect prediction, Variant annotation, Genomic variation, Sequence analysis, Protein-coding
transcript, Indel, SNV, Insertion, DeletionFindings
Introduction
One central goal of many genomics projects is to detect
different types of genomic variations (GVs) and to
understand how these GVs explain differences at the
phenotypic level, for example, between healthy and dis-
eased individuals [1,2]. Accurate and comprehensive de-
tection of GVs, including single-nucleotide variations
(SNVs), insertions and deletions, has been greatly facili-
tated by the development of next generation sequencing
technologies [3] and variation detection methods [4].
After GVs are defined, evaluation of their functional
impact on protein-coding transcripts becomes the pri-
mary focus. Many programs have been developed for
this task, of which Ensembl’s Variant Effect Predictor
(VEP) [5], GATK’s VariantAnnotator [6], Sequence Vari-
ant Analyzer (SVA) [7] and ANNOVAR [8] are among
the more popular ones.* Correspondence: chenn@sfu.ca
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reproduction in any medium, provided the orCurrent variant annotation programs have important
limitations. First, they assess the effects of multiple co-
occurring GVs on the same transcript independently,
which can be problematic when nearby GVs alter each
other’s effect [9]. For example, a small deletion can re-
store the open reading frame (ORF) disrupted by a small
insertion co-occurring nearby on the same transcript. A
second limitation is that most programs are tightly
coupled to external databases, making their use incon-
venient or even impractical for users who work on
organisms whose genome sequence or annotation is not
available in these databases.Implementation
We have developed an easy-to-use Perl program named
CooVar (Co-occurring Variant Analyzer) to address
these limitations. CooVar takes as input (i) a list of GVs
in the popular Variant Call Format (VCF) [10] or in a
simpler tab-delimited file format, (ii) the reference gen-
omic DNA sequence in FASTA format, and (iii) protein-
coding exon coordinates in GFF or GTF format.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[11] reporting the functional impact of each input GV
on transcripts, and a GFF file including (i) the transcript
models, (ii) all GVs impacting each transcript, and (iii) a
prediction of how GVs impact the function of each tran-
script. The functional impact of GVs on protein-coding
transcripts is annotated as: ORF_INTACT, if the tran-
script is not impacted by any GVs; ORF_PRESERVED,
if the transcript is impacted by GVs but these GVs do
not introduce internal stop or splice site variants;
ORF_DISRUPTED, if an internal stop or splice site vari-
ant is present; and FULLY_DELETED, if the transcript is
deleted. In the case of a transcript that has its ORF
disrupted by an internal stop codon, CooVar provides
the percentage location of the first internal stop codon
in the variant peptide compared to the reference.
CooVar classifies GVs according to the GVF v1.05 spe-
cification for structural variants described in the Se-
quence Ontology (SO) Project [12]. For SNVs, these
categories include silent_mutation, synonymous_codon,
conservative_missense_codon, non_conservative_missense_
codon, stop_gained, stop_lost, splice_acceptor_variant,
and splice_donor_variant. Insertions and deletions are
classified into the categories silent_mutation, frame-
shift_variant, inframe_variant, splice_acceptor_variant,
and splice_donor_variant. The functional impact of
missense SNVs causing amino acid changes is further
evaluated with the Grantham score [13] and annotated
as CONSERVATIVE or MODERATELY_CONSERVATIVE
(both classified as conservative_missense_codon) and
MODERATELY_RADICAL or RADICAL (both classified
as non_conservative_missense_codon) [14]. For SNVs
impacting protein-coding exons, CooVar also reports
both the amino acid change and the codon change be-
tween the reference genome and the variant. This allows
the user to observe immediately if a change in a codon
is caused by one, two or three co-occurring substitutions
at the same codon. Furthermore, CooVar lists separately
all those SNVs that fall into multiple categories by
impacting two or more protein-coding transcripts differ-
ently (e.g. synonymous vs. missense).
In addition to the annotation of individual transcripts
and GVs, CooVar outputs various summary statistics.
For example, CooVar generates statistics on the codon
bias for synonymous versus non-synonymous SNVs. In
two other files CooVar outputs the length distribution of
indels across the whole genome versus the length distri-
bution of indels impacting only protein-coding tran-
scripts as a way to detect biases towards non-frameshift
indels in exonic regions. The file variant.stat provides
information on the distribution of internal stop codons
and on the total number of transcripts affected by SNVs,
insertions and deletions, or by any combination of those.
If the –circos flag is used, CooVar computes the genomicdistribution of SNVs, insertions, deletions and coding
exons in a format compatible with the Circos tool for
visualization [15].
One advantage of CooVar over other programs is that
it provides full-length variant transcript and protein
sequences in FASTA format as output, which can be
useful for downstream analyses (for example for se-
quence alignments). The same information is provided
at the exon level in two additional files. Since a direct
comparison between the reference and variant transcript
is also desirable, CooVar provides an exon-based align-
ment of reference and variant sequences for each tran-
script, with variant nucleotides marked in uppercase.
This makes it easy to spot all SNVs, insertions and dele-
tions that impact a given protein-coding transcript in a
region of interest.
Another commonly requested feature in variant anno-
tation is to identify GVs that overlap with protein
domains. This is because GVs affecting conserved
domains are more likely to be of functional importance.
With CooVar this analysis can be performed in two
steps. First, the script protein2genome.pl can be used to
map protein (domain) coordinates to the genome, which
generates a GFF file with genomic coordinates. The
script annotate-regions.pl can then be used to compute
the overlap between this GFF file and the CooVar GVF
output file. Overlap computation is performed efficiently
using interval trees and generally finishes within a few
minutes, even for very large data sets. The result of this
two-step process is a new GVF file in which GVs are
annotated with the protein domains they overlap with. It
is worth mentioning that annotate-regions.pl script is
generic and can also be used to annotate GVs that over-
lap with non-protein-coding regions (for example tran-
scription factor binding sites) as long as coordinates for
these regions are provided in the required input GFF
format.
More detailed information about program parameters
and input file formats can be found in the program
README file or in the Perl scripts themselves.
Results and discussion
We have tested CooVar on two datasets, both of which
are available from the project website. The first dataset
corresponds to 120,638 GVs (116,999 SNVs, 1,553 inser-
tions ranging from 1 to 34 bp in length and 2,086 dele-
tions ranging from 1 to 24 bp in length) detected in the
Hawaiian isolate CB4856 of the model organism Caenor-
habditis elegans. CB4856 GVs, the N2 reference genome
(isolated in Bristol, England) and 24,256 annotated N2
protein-coding transcript models were obtained from
WormBase release WS210 [16]. CooVar had a proces-
sing time of 10 minutes for this data set and classified
15,293 transcripts as ORF_INTACT, 8,446 transcripts
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DISRUPTED. Figure 1 shows a Circos image with the
distribution of SNVs, deletions, and insertions along
the six C. elegans chromosomes. This image was gener-
ated by using the CooVar output files (option –circos) as
input for Circos (version 0.62-1) [15].Figure 1 Distribution of SNVs, insertions, and deletions along the C. e
the outside represent the six C. elegans chromosomes. Going from outside
higher density), histograms represent the density of deletions (also drawn i
higher density) detected in the Hawaiian isolate CB4856. Note the generall
chromosome-internal peaks on chromosome IV and V. Data points for this
option. Circos was then used to generate the image. Circos configuration f
C. elegans test data set at http://genome.sfu.ca/projects/coovar/.The second dataset contains 4,044,200 human GVs
detected in an anonymous individual (HG00732-200-37-
ASM) sequenced by Complete Genomics. This data set
was recently made publicly available for the research
community as part of a larger 69 genome data set
[17,18]. HG00732-200-37-ASM variants were firstlegans genome for Hawaiian isolate CB4856. Segmented rings on
to inside, the line plot shows SNV density (inward pointing peaks =
nwards), and the heatmap depicts the density of insertions (dark red =
y higher density of SNVs towards the telomeres and the presence of
image were automatically generated by CooVar using the –circos
iles necessary to create this type of image are provided with the
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[10]. We then discarded all but the first alternative allele
and used the filtered VCF file as input to CooVar. The
genomic reference sequence and the protein-coding
gene set were both obtained from the Ensembl web site
(release GRCh37.68, hg19). For comparison, we anno-
tated the exact same VCF file with Ensembl’s Variant Ef-
fect Predictor (VEP) [5]. VEP was run locally using the
Perl script variant_effect_predictor.pl and configured
to retrieve Ensembl data (release 68) over the internet
(−−host useastdb.ensembl.org). The VEP output for the
HG00732-200-37-ASM data set can be downloaded
from the CooVar project homepage.
Results of this comparison are summarized in Table 1.
CooVar took 36 minutes to process the complete human
data set and reported 4,158,840 annotated variants. VEP
outputted 4,043,939 variants and finished within 37
hours and 24 minutes. The overall increased number of
variants reported by CooVar is because CooVar decom-
poses compound input VCF variants into sometimes
multiple SNV and indel variants, which are then anno-
tated and reported separately. For example, CooVar
decomposes a VCF input variant with the reference allele
“ATG” and the alternative allele “AC” into one SNV
(T->C) and one deletion variant (with G being theTable 1 Comparison of GVs annotated with CooVar and
VEP for human individual HG00732-200-37-ASM
CooVar VEP
Runtime 36m 37h 24m
Total reported GVs 4,158,840 4,043,939
Intronic/intergenic/UTR 4,133,885 4,019,490
Impacting protein-coding exon 24,955 24,449
Synonymous/stop retained 11,585 11,434
Missense 12,011 11,576
Conservative (%)$ 9,526 (79.3) 7,447 (64.3)
Non-conservative (%)+ 2,485 (20.7) 2,110 (18.3)
Unknown consequence (%) 0 (0) 2,019 (17.4)
Splice donor/acceptor 97 184
Stop lost 47 46





ORF disrupted 782¥ 871§
Each GV reported by CooVar (v0.05) and VEP (v2.6) was assigned to one (and
only one) of the above categories. $ CooVar: Grantham score conservative or
moderately conservative; VEP: SIFT benign; + CooVar: Grantham score
moderately radical or radical; VEP: SIFT deleterious. * GVs assigned to more than
one category due to differential impact on different transcripts. ¥ Presence of
internal stop codon within the first 70% of ORF length, after applying all
variants. § Predicted frameshift or stop gain variant within the first 70% of ORF
length. Abbreviations: GV . . . genomic variation; ORF . . . open reading frame;
VEP. . . Variant Effect Predictor; UTR. . . untranslated region.deleted base in this case). In contrast, VEP will annotate
such compound variants as a single variant, resulting in
sometimes ambiguous or nonspecific classification
results (see examples below).
As expected, both programs classify the vast majority
of variants as not impacting protein-coding exons
(Table 1, category intronic/intergenic/UTR). Only 0.6%
of all variants (24,955 variants by CooVar and 24,449 by
VEP) are predicted to impact protein-coding exons in
some form. To allow for a detailed comparison of anno-
tation results, we assigned variants impacting protein-
coding exons into one (and only one) of the following
categories: variants not altering protein translation
(synonymous/stop retained); variants altering protein
translation (missense); variants impacting AG/GT splice
site di-nucleotides (splice donor/acceptor); variants lead-
ing to stop codon loss (stop lost) or gain (stop gained);
and insertions or deletions that shift (frameshift) or pre-
serve the open reading frame (inframe). Thirty-one
VEP variants could not be assigned to one of these
categories and were classified as other. This includes
variants that VEP nonspecifically annotated as coding_
sequence_variant. A number of variants (409 for CooVar,
389 for VEP) could not be unambiguously assigned to a
single category because they impact multiple transcripts
differently and were classified as multiple.
Overall, we find that numbers of GVs in each category
agree well between CooVar and VEP (Table 1). Both pro-
grams predict ~11,500 synonymous variants and about
the same number of missense variants. CooVar’s
Grantham score classifies ~20% of missense variants as
moderately radical or radical, which agrees well with
the VEP SIFT classification scheme that predicts 18% of
missense variants to be deleterious. Both programs pre-
dict about 50 stop lost mutations and 135 stop gain
mutations. Interestingly, VEP predicts 20 more frame-
shift variants than CooVar (490 vs. 470 variants) and 34
less inframe variants (165 vs. 199 variants). Also, the
number of predicted splice site variants is markedly dif-
ferent between the two programs, with almost twice as
many splice site variants predicted by VEP (184 variants)
than CooVar (97 variants).
To understand the nature of these differences, we per-
formed a detailed manual analysis of GVs that were differ-
ently annotated between CooVar and VEP. In general, we
find that the main source of discrepancy between CooVar
and VEP is due to the fact that CooVar but not VEP
recognized the presence of SNVs within more complex or
compound VCF input variants. For example, reference
and alternative allele in the VCF input variant 11:11,292,688:
GGGTCAGGACGCG->GGGTCAGGACGCC differ by only
a single SNV (G->C, underlined). CooVar correctly reports
this variant as synonymous SNV while VEP annotates it less
specifically as coding_sequence_variant, without information
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gained variants are attributable to the same effect. For ex-
ample, CooVar interprets multi-SNV variant 19:43,922,549:
AGA->TGC as stop lost variant while VEP annotates it as
coding_sequence_variant and 3_prime_UTR_variant. Manual
inspection showed that the first of the three SNVs encoded by
this input variant (A->T) indeed changes the stop codon of
transcript ENST00000253435 from TAA to TAT, suggesting
that the CooVar prediction is correct.
The much larger number of splice site variants predicted
by VEP is also explained by the higher resolution with
which CooVar decomposes complex VCF input variants.
For example, variant 11:117,303,853:CCCAGT->CCCAGC
is annotated as splice donor variant by VEP but not Coo-
Var, which reports it as synonymous SNV. Manual inspec-
tion showed that the coordinates of this variant
(117,303,853–117,303,858) indeed overlap with a donor
splice site of transcript ENST00000527706, but the actual
SNV encoded by this variant (T->C) is in fact synonymous.
Thus, in this case, a simple coordinate overlap analysis as
seems to be performed by VEP produces an incorrect re-
sult. Other examples of this type include variant
7:101,194,424:CGTAA->TGTAA (CooVar: synonymous),
5:159,835,654:TACCA->TACCG (CooVar: missense), or
19:16,612,363:GTG->GTA (CooVar: silent).
Complex input variants also account for discrepancies
observed between indel annotations. We randomly picked
and examined 10 of the 34 inframe variants predicted by
CooVar but not VEP. For 9 out of these, we find that they




length difference is a multiple of 3 in both cases). Why VEP
classifies these variants as missense variants was not obvi-
ous to us. The remaining variant of these ten variants was
actually classified as inframe variant by VEP but assigned to
category multiple by our classification scheme because VEP
predicts it as both inframe and stop gained variant.
Another main source of discrepancy in indel classification
arose from so called “boundary indels”. We refer to boundary
indels as indels that fall right next to the start or end of cod-
ing exons, thus leaving some uncertainty about the exact im-
pact of these variants on the protein-coding transcript.
Variant 7:142,494,013 is an example of an insertion where
the exact placement of the inserted sequence is ambiguous,
resulting in a predicted frameshift insertion by CooVar but
in a predicted coding_sequence_variant and 5_prime_UTR_
variant by VEP. Most of the frameshift variants predicted by
VEP but not CooVar represent boundary indels. Representa-
tive examples include 11:111,853,106:G->GC (1-bp insertion
right before coding exon), 16:76,311,602:G->GT (1-bp inser-
tion right after coding exon), 16:31,770,696:GA->GAA (1-bp
insertion into start codon), and 17:39,254,335:AT->ATT(1-bp insertion before start codon). We manually inspected
all 20 frameshift variants predicted by VEP but not CooVar
and confirm that CooVar predictions appear to be correct, i.
e. these variants are likely not causing frameshift mutations
in affected transcripts.
We were also interested in the number of ORFs that
were predicted to be disrupted by both CooVar and
VEP. For this particular comparison, we defined a Coo-
Var ORF as being disrupted if an internal stop codon oc-
curred within the first 70% of the ORF’s length after
applying all GVs to a transcript. CooVar provides the
position of the first internal stop codon as part of its
output. VEP does not provide ORF status information in
its output, so we defined a VEP ORF as being disrupted
if VEP predicted at least one frameshift or stop gain
variant within the first 70% of the ORF’s length. Using
these criteria, we find that CooVar predicts 782 ORFs to
be disrupted while VEP predicts 871 ORFs as disrupted
(Table 1). We inspected about half (48) of the transcripts
that had assigned a different ORF status by the two pro-
grams and found that most of them (20 ORFs, e.g. tran-
script ENST00000376343) carry a frame-shifting indel
that does not introduce an internal stop codon albeit it
changes the translated protein sequence downstream.
Thus, although for these transcripts a significant portion
of the ORF (>30%) is changed in terms of its protein se-
quence, the length of the ORF remains intact. Seventeen
of the 48 inspected transcripts (e.g. ENST00000222270)
had a frameshift predicted by VEP but not CooVar due
to boundary indels as discussed above. Five of the 48
transcripts had already internal stop codons in the refer-
ence sequence and hence were not annotated as dis-
rupted by CooVar.
Most importantly, the remaining six ORFs predicted to
be disrupted by VEP but not CooVar carry neighboring
indels that cancel each others effect, restoring the open
reading frame. Figure 2A shows one such example affect-
ing Ensembl transcript ENST00000253255. This transcript
carries a 1bp insertion at position 22:46,658,224 and a
nearby 1bp deletion at position 22:46,658,220. When eval-
uated independently, the impact of the insertion and the
deletion on this transcript is a frameshift mutation, dis-
rupting the ORF. But when evaluating the joint effect that
these GVs have on the transcript it results in a preserved
ORF, as reported by CooVar. A similar issue arises from
co-occurring SNVs. In the example shown in Figure 2B,
VEP classifies SNV 10:27,702,726:G->A as synonymous
because it changes codon CTG on the reverse strand (cod-
ing for leucine) to TTG (also coding for leucine). How-
ever, CooVar considers the combined effect of this SNV
and a neighboring SNV (10:27,702,725:A->G) that affects
the same codon. When evaluated together, 10:27702726:
G->A is recognized by CooVar as missense SNV that
changes the codon from CTG to TCG, which codes for
Figure 2 GVs affecting the same protein-coding transcript must be assessed together to correctly predict their functional impact. Panel
A shows an example where two neighboring frameshift indels (1-bp insertion and 1-bp deletion, indicated by arrows) cancel each others effect,
restoring the original ORF. Panel B shows an example where an otherwise synonymous SNV (G->A, indicated by arrow) causes a missense
mutation due to the effect of a neighboring SNV (A->G). In both panels, the first three rows show the reference nucleotide sequence on the
forward strand, the reference nucleotide sequence from the reverse strand, and the reference protein sequence translation from the annotated
ORF. Note that both ORFs are encoded on the reverse strand, so sequences must be read from right to left. The track below shows the variant
sequence detected in human individual HG00732-200-37-ASM, with critical GVs highlighted by arrows. The blue horizontal bar represents the
Ensembl protein-coding transcript spanning this genomic region.
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portance of assessing the impact of co-occurring GVs to-
gether to correctly judge their functional impact [9].
We conclude that CooVar is a fast and light-weight al-
ternative to currently existing variant annotation tools that
is particularly useful for non-model organisms. CooVar
produces very similar results as other popular tools, but,
under certain circumstances, generates biologically more
accurate annotations by considering the combined effect
of co-occurring GVs on protein-coding transcripts.Availability and requirements
Project name: CooVar: Co-occurring Variant Analyzer
Project home page: http://genome.sfu.ca/projects/coovar
Operating system(s): Windows, Linux, Mac OS-X
Programming language: Perl 5.8.8
Other requirements: The following Perl modules are
required by CooVar and need to be installed: Cwd,
Getopt::Long, POSIX, File::Basename, List::Util, Bio::DB::
Fasta, Bio::Seq, Bio::SeqUtils, Bio::SeqIO, Set::Interval-
Tree, Set::IntSpan
License: GNU GPL
Any restrictions to use by non-academics: none
The latest version of the program can be obtained from
the project webpage. CooVar version 0.05 is included as
online supplementary material (Additional file 1).
Additional file
Additional file 1: CooVar program tarball (version 0.05), including
README and test scripts.Abbreviations
GV: Genomic Variation; GFF: Generic Feature Format; GTF: Gene Transfer
Format; SNV: Single Nucleotide Variant; Indel: Insertion or deletion;
GVF: Genomic Variant Format; ORF: Open Reading Frame; VCF: Variant Call
Format.
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